Results 91 to 100 of about 101,889 (202)

REAL-WORLD EXPERIENCE WITH JANUS KINASE INHIBITORS IN EXTRAINTESTINAL MANIFESTATIONS AND INFLAMMATORY BOWEL DISEASE IN COLOMBIA: A COMPARATIVE STUDY (JAKEIM-IBD STUDY) [PDF]

open access: yesArquivos de Gastroenterologia
Background: Extraintestinal manifestations (EIMs) significantly impact patients with inflammatory bowel disease (IBD). Janus kinase inhibitors (JAKi) are emerging as a potential treatment.
Viviana PARRA-IZQUIERDO   +8 more
doaj   +1 more source

A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.

open access: yes, 1985
While differentiation of leukemic cells in vitro is well established, the role of differentiation in vivo is not defined and is generally attributed to differentiation inducers. In five patients with acute promyelocytic leukemia (APL) an unusual pattern
W Hittleman   +7 more
core   +1 more source

Mycophenolate mofetil for remission induction in severe lupus nephritis

open access: yes, 2005
Background: Mycophenolate mofetil (MMF) is a potential alternative immunosuppressive to cyclophosphamide or azathioprine for the treatment of lupus nephritis.
Gordon, C   +12 more
core   +1 more source

Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis

open access: yes, 2016
Oral corticosteroids are the mainstay treatment for induction of ulcerative colitis remission in patients failing or intolerant to aminosalicylate therapy, but the poor tolerability profile of these drugs limits their usefulness.
D'Haens, G.
core   +1 more source

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

open access: yesHaematologica, 2008
The Wilms’ tumor gene WT1 is a reliable marker for minimal residual disease assessment in acute leukemia patients. The study was designed to demonstrate the potential use of WT1 to establish quality of remission in acute leukemia patients for early ...
Daniela Cilloni   +15 more
doaj   +1 more source

CD26: A prognostic marker of acute lymphoblastic leukemia in children in the post remission induction phase

open access: yes, 2015
Background: ALL is an irredeemable disease due to the resistance to treatment. There are several influences which are involved in such resistance to chemotherapy, including oxidative stress as a result of the generation of reactive oxygen species (ROS)
Zainulabdeen, Jwan Abdulmohsin   +3 more
core   +1 more source

Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions

open access: yesBiomedicines
The management of elderly patients diagnosed with acute myelogenous leukemia (AML) is complicated by high relapse risk and comorbidities that often preclude access to allogeneic hematopoietic cellular transplantation (allo-HCT).
Paul Sackstein   +5 more
doaj   +1 more source

Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease

open access: yesBMC Gastroenterology, 2018
Background Exclusive enteral nutrition (EEN) is as effective as corticosteroids in inducing remission in children with Crohn’s disease (CD). However, over 50% of these children relapse by 12 months of diagnosis.
Christina Ong   +7 more
doaj   +1 more source

‘Daring to peek over the wall’: A qualitative exploration of the concept of remission in the process of recovery for people with schizophrenia

open access: yes
Remission is synonymous within cancer care and with other physical disorders, but less known and utilised in relation to people with a diagnosis of schizophrenia. Following work by Andreasen et al (2005) the idea of remission in schizophrenia became more
Ford, Keith
core  

Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly. [PDF]

open access: yesClin Rheumatol, 2023
Aqeel F   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy